Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Firestein

Showing results (271-280 of 386) with videos related to

Pageof 39
Sort By:
Annals of the Rheumatic Diseases|October 3, 2014
Choline kinase inhibition in rheumatoid arthritisM Guma, E Sanchez-Lopez, A Lodi, et al.
The American Journal of Pathology|March 22, 2012
PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritisBeatrix Bartok, David L Boyle, Yi Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritisD L Boyle, E A Kowaluk, M F Jarvis, et al.
The Journal of Bone and Joint Surgery. American Volume|September 5, 2006
Effect of impact on chondrocyte viability during insertion of human osteochondral graftsBoris H Borazjani, Albert C Chen, Won C Bae, et al.
Plos Medicine|September 7, 2006
Regulation of peripheral inflammation by spinal p38 MAP kinase in ratsDavid L Boyle, Toni L Jones, Deepa Hammaker, et al.
The American Journal of Physiology|January 22, 1998
Adenosine kinase inhibitor GP515 attenuates hepatic leukocyte adhesion after hemorrhagic hypotensionC Bauer, M G Bouma, I Herrmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2010
JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritisMonica Guma, Jun-ichi Kashiwakura, Brian Crain, et al.
Annals of the Rheumatic Diseases|January 11, 2011
Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritisMaripat Corr, David L Boyle, Lisa M Ronacher, et al.
Biotechnology and Bioengineering|December 17, 2009
Semi-permeable membrane retention of synovial fluid lubricants hyaluronan and proteoglycan 4 for a biomimetic bioreactorMegan E Blewis, Brian J Lao, Kyle D Jadin, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 11, 2019
Toreforant, an orally active histamine H<sub>4</sub>-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy studyDavid L Boyle, Samuel E DePrimo, Cesar Calderon, et al.
Pageof 39

Showing results (271-280 of 386) with videos related to

Sort By:
Pageof 39
Annals of the Rheumatic Diseases|October 3, 2014
Choline kinase inhibition in rheumatoid arthritisM Guma, E Sanchez-Lopez, A Lodi, et al.
The American Journal of Pathology|March 22, 2012
PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritisBeatrix Bartok, David L Boyle, Yi Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritisD L Boyle, E A Kowaluk, M F Jarvis, et al.
The Journal of Bone and Joint Surgery. American Volume|September 5, 2006
Effect of impact on chondrocyte viability during insertion of human osteochondral graftsBoris H Borazjani, Albert C Chen, Won C Bae, et al.
Plos Medicine|September 7, 2006
Regulation of peripheral inflammation by spinal p38 MAP kinase in ratsDavid L Boyle, Toni L Jones, Deepa Hammaker, et al.
The American Journal of Physiology|January 22, 1998
Adenosine kinase inhibitor GP515 attenuates hepatic leukocyte adhesion after hemorrhagic hypotensionC Bauer, M G Bouma, I Herrmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2010
JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritisMonica Guma, Jun-ichi Kashiwakura, Brian Crain, et al.
Annals of the Rheumatic Diseases|January 11, 2011
Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritisMaripat Corr, David L Boyle, Lisa M Ronacher, et al.
Biotechnology and Bioengineering|December 17, 2009
Semi-permeable membrane retention of synovial fluid lubricants hyaluronan and proteoglycan 4 for a biomimetic bioreactorMegan E Blewis, Brian J Lao, Kyle D Jadin, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 11, 2019
Toreforant, an orally active histamine H<sub>4</sub>-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy studyDavid L Boyle, Samuel E DePrimo, Cesar Calderon, et al.
Pageof 39